Pharmaron Beijing Co., Ltd. (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Pharmaron Beijing Total Liabilities (Quarterly) : 1.715B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.715B |
| March 31, 2026 | 1.657B |
| December 31, 2025 | 1.584B |
| September 30, 2025 | 1.492B |
| June 30, 2025 | 1.405B |
| March 31, 2025 | 1.336B |
| December 31, 2024 | 1.291B |
| September 30, 2024 | 1.360B |
| June 30, 2024 | 1.283B |
| March 31, 2024 | 1.661B |
| December 31, 2023 | 1.811B |
| September 30, 2023 | 1.362B |
| June 30, 2023 | 1.388B |
| March 31, 2023 | 1.422B |
| December 31, 2022 | 1.395B |
| September 30, 2022 | 1.293B |
| June 30, 2022 | 1.296B |
| Date | Value |
|---|---|
| March 31, 2022 | 1.311B |
| December 31, 2021 | 1.246B |
| September 30, 2021 | 1.181B |
| June 30, 2021 | 1.166B |
| March 31, 2021 | 550.70M |
| December 31, 2020 | 430.74M |
| September 30, 2020 | 287.27M |
| June 30, 2020 | 234.80M |
| March 31, 2020 | 191.17M |
| December 31, 2019 | 285.03M |
| September 30, 2019 | 350.68M |
| June 30, 2019 | 339.91M |
| March 31, 2019 | 343.80M |
| December 31, 2018 | 345.85M |
| September 30, 2018 | 311.67M |
| June 30, 2018 | 313.13M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Viva Biotech Holdings | -- |
| ICON plc | 7.022B |
| Proteome Sciences Plc | -- |
| Champions Oncology, Inc. | 22.92M |
| SPO Global, Inc. | 0.3183M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.294B |
| Shareholders Equity (Quarterly) | 2.409B |
| Debt to Equity Ratio | 0.4253 |
| Current Ratio | 1.017 |
| Net Debt Paydown Yield | -1.15% |